GLAXOSMITHKLINE

Sanofi-Aventis said on Wednesday a group of independent experts had concluded that studies highlighting a possible link between its Lantus diabetes drug and an increased risk of cancer were flawed.

The United States will spend another $1 billion on ingredients for an H1N1 vaccine, U.S. Health and Human Services Secretary Kathleen Sebelius said on Sunday.

The first H1N1 infection found to be resistant to the antiviral drug Tamiflu represents an isolated case with no current implications for public health, the World Health Organization (WHO) said on Tuesday.

The new bosses at Sanofi-Aventis and GlaxoSmithKline are playing a cautious acquisition game, 13 and seven months respectively after taking control of the two big European drugmakers.

GlaxoSmithKline's chief executive acknowledged on Friday that overhauling its drug discovery machine had been traumatic but said turning back the clock on R&D was now delivering results.

Swiss drugs company Novartis will not give free vaccines against H1N1 flu to poor countries, though it will consider discounts, the Financial Times reported on Sunday.

GlaxoSmithKline took another step in building its business in emerging markets on Monday by signing an alliance with Indian generic drugmaker Dr Reddy's Laboratories.

A diabetes drug from Switzerland's Roche Holding AG showed promising results in a mid-stage trial and will be developed further, the company said on Monday.

An experimental cancer pill from GlaxoSmithKline reduced the risk of tumour progression or death by 54 percent in advanced kidney cancer patients compared to placebo, trial results showed on Monday.

British drug firm GlaxoSmithKline Plc is in talks to buy a 51 percent stake in India's unlisted Shantha Biotech after prospective bidder Sanofi Aventis dropped out, the Economic Times said on Friday.

The United States could authorize emergency use of some currently unapproved immune system boosters called adjuvants to make a swine flu vaccine more effective, an official at the U.S. Centers for Disease Control and Prevention said on Thursday.

British-based drug company GlaxoSmithKline is battling the U.S. Internal Revenue Service over a potential $1.9 billion in back taxes, interest and penalties.

The new flu strain is spreading widely in the United States and Japan and is likely to circulate worldwide, health officials said on Monday.

The World Health Organization warned on Friday against a false sense of security from waning and apparently mild outbreaks of H1N1 flu, saying the worst may not be over.

GlaxoSmithKline will take a 16 percent stake in Africa's biggest generic drug maker, Aspen Pharmacare, to expand its emerging market footprint in a deal worth 3.47 billion rand ($418 million).

The threat of a pandemic triggered by a new 'flu strain that has killed 103 people in Mexico will provide a windfall for some makers of drugs and vaccines.

GlaxoSmithKline Plc is to buy privately owned Stiefel Laboratories Inc for up to $3.6 billion to diversify its business by adding treatments for acne, dermatitis and other skin complaints.

British-based pharmaceuticals firm GlaxoSmithKline PLC is in talks to buy privately-owned U.S. skincare specialist Stiefel Laboratories, a source familiar with the situation said on Sunday.

British-based pharmaceuticals firm GlaxoSmithKline PLC is in talks to buy privately-owned U.S. skincare specialist Stiefel Laboratories, a source familiar with the situation said on Sunday.

GlaxoSmithKline PLC is close to a deal to buy U.S. skincare specialist Stiefel Laboratories for about $3 billion, the Wall Street Journal said on its website on Sunday, citing unnamed sources.

Stiefel Laboratories Inc, a privately held pharmaceutical maker, is considering selling itself in a deal that could be worth several billion dollars, the Wall Street Journal said, citing people familiar with the matter. The potential sale has drawn interest from a number of major drug companies, including Johnson & Johnson , Novartis AG and GlaxoSmithKline PLC